Brief

The Commission Implementing Regulation (EU) 2024/2563 amends Implementing Regulation (EU) 2022/1646 to enhance national risk-based control plans and surveillance plans for pharmacologically active substances. The regulation updates requirements for submitting data by Member States, sampling frequencies, and minimum percentages of samples for substance group A(3), point (b).

This content is restricted.

Highlights content goes here...

This content is restricted.

Register of Delegated and Implementing Acts

Quick Insight
RADA.AI
RADA.AI
Hello! I'm RADA.AI - Regulatory Analysis and Decision Assistance. Your Intelligent guide for compliance and decision-making. How can i assist you today?
Suggested

Form successfully submitted. One of our GRI rep will contact you shortly

Thanking You!

Enter your Email

Enter your registered username/email id.

Enter your Email

Enter your email id below to signup.
Individual Plan
$125 / month OR $1250 / year
Features
Best for: Researchers, Legal professionals, Academics
Enterprise Plan
Contact for Pricing
Features
Best for: Law Firms, Corporations, Government Bodies